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spectively. DASH-DS and DASH-W were as moderately sen-
sitive as VAS for pain.
Conclusion. The DASH-DS and DASH-W Japanese version
have evaluation capacities equivalent to those of the original
and other language versions of the DASH.
Introduction
Upper extremity disorder can limit the activities of suf-
ferers and have negative effects on their quality of life
(QOL) and work activity. It is a common disorder and a
costly health problem in the general population and in
the workplace.1,2 Numerous epidemiological studies as
well as those on psychosocial factors of upper extremity
disorders in the workplace have been systematically re-
viewed and summarized.1,2
Health status is an important patient outcome used to
evaluate medical (especially surgical3) intervention
and in ergonomic studies.4 Several measures for the
evaluation of upper extremity function have been
developed.5–10 Most of them are joint-specific5,10 or
disease-specific.7,8 Others are intended to evaluate the
function of the entire upper extremity using a region-
specific measure.6,9 The Disability of the Arm, Shoulder,
and Hand (DASH) questionnaire was devised as a
region-specific measure by the American Academy of
Orthopaedic Surgeons (AAOS) in collaboration with a
number of other organizations.6 The rationale for use of
this measure is that the upper extremity is a functional
unit or kinetic chain.11 Therefore, the DASH is suitable
for measuring health status outcome because it is
mainly a measure of disability.
The DASH is now available in several languages,12–18
and studies of its reliability and validity have been pub-
Abstract
Background. The Disability of the Arm, Shoulder and Hand
(DASH) questionnaire is a region-specific self-administered
questionnaire that consists of a disability/symptom (DASH-
DS) scale, and two optional modules, the work (DASH-W)
and the sport/music (DASH-SM) modules. The DASH was
cross-culturally adapted and developed by the Impairment
Evaluation Committee, Japanese Society for Surgery of the
Hand. The purpose of this study was to test the reliability,
validity, and responsiveness of the Japanese version of DASH
(DASH-JSSH).
Methods. A series of 72 patients with upper extremity
disorders completed the DASH-JSSH, the medical outcomes
study 36-item short-form health survey (SF-36), and the
Visual Analog Scale (VAS) for pain. Thirty-eight of the
patients were reassessed for test-retest reliability 1 or 2 weeks
later. Reliability was investigated by reproducibility and inter-
nal consistency. To analyze the validity, a principal compo-
nent analysis and correlation coefficients between the
DASH-JSSH and the SF-36 were obtained. Responsiveness
was examined by calculating the standardized response mean
(mean change/SD) and effect size (mean change/SD of base-
line value) after carpal tunnel release of the 17 patients with
carpal tunnel syndrome.
Results. Cronbach’s alpha coefficients in the DASH-DS and
DASH-W were 0.962 and 0.967, respectively. The intraclass
correlation coefficients for the same were 0.82 and 0.85, re-
spectively. The unidimensionality of the DASH-DS and
DASH-W were confirmed. The correlations between the
DASH-DS score and the subscale of the SF-36 scale ranged
from -0.29 to -0.73. The correlation coefficient between the
DASH-DS and the DASH-W was 0.79. The standardized re-
sponse mean/effect size of DASH-DS, DASH-W, and VAS
for pain were -0.48/-0.26, -0.68/-0.41, and -0.40/-0.40, re-
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lished for not only the original version3 but also for the
Swedish,12 German,14 Spanish,15 Dutch,16 Italian,17 and
Chinese18 versions. However, one of the optional
DASH modules, the work module, has not been studied
except in the Italian and Chinese versions.17,18 We, the
Impairment Evaluation Committee (Japanese Society
for Surgery of the Hand), have completed cross-cultural
adaptation and developed the DASH Japanese version
(DASH-JSSH). The purpose of this study was to test
the reliability, validity, and responsiveness of the
DASH-JSSH (including the work module) and to make
the DASH-JSSH available for use in Japan.
Material and methods
In accordance with published guidelines,19,20 we
organized the DASH-JSSH committee consisting of
translators, researchers, a methodologist, and a
Japanese-language expert.
Adaptation process
The English version of the DASH (version 2.0) was
translated into Japanese by two translators whose first
language was Japanese. One of them had no medical
background, and the other did. Their two “forward”
translations were synthesized into one after being re-
viewed and discussed by the committee. This Japanese
version (prefinal version) was translated back into
English by two other translators whose first language
was English. One of them was blinded to the concepts
being investigated and had no medical background. The
other had a medical background. We collected pilot test
data and submitted it with the DASH-JSSH (prefinal
version) to the AAOS in 2002. They suggested that the
DASH-JSSH (prefinal version) needed to be modified
in terms of cultural adaptation. Following their sugges-
tions, our committee modified the DASH-JSSH
prefinal version into a new, final version. The final
DASH-JSSH version was then evaluated with regard to
reliability, validity, and responsiveness.
DASH questionnaire
The main part of the DASH is a 30-item disability/
symptom (DASH-DS) scale concerning the patient’s
upper extremity.3,6 Each item has five response choices,
ranging from “no difficulty or no symptom” to “unable
to perform activity or very severe symptom.” It is scored
on a scale of 1–5. The items ask about the severity of
each of the symptoms of pain, activity-related pain, tin-
gling, weakness, and stiffness (five items: numbers 24–
28); the degree of difficulty when performing various
physical activities because of an arm, shoulder, or hand
problem (21 items: numbers 1–21); the effect of the
upper extremity problem on social activities, work, and
sleep (three items: numbers 22, 23, 29); and the psycho-
logical effect on self-image (one item: number 30).
These provide the DASH disability/symptom (DASH-
DS) score ranging from 0 (no disability) to 100 (the
severest disability), after summation of the scores from
all items and transformation.
The DASH also contains two optional modules con-
cerning the ability to work and the ability to perform
sports or play musical instruments. These two optional
modules each consists of four items, each of which is
rated on a scale of 1–5. These provide the DASH work
(DASH-W) score and the DASH sport/music (DASH-
SM) score ranging from 0 (no disability) to 100 (the
severest disability) after summation of the scores from
all items and transformation.
Patients and setting
A series of 73 patients with upper extremity disorders
were seen on an outpatient basis in five orthopedic sur-
gery departments in Japan. Exclusion criteria were age
below 18 years and relevant co-morbidity (e.g., connec-
tive tissue disease). One patient with a co-morbidity of
systemic lupus erythematosus (SLE) was excluded. The
study was thus conducted on 72 patients (17 men, 55
women) who were suffering from carpal tunnel syn-
drome (38 patients), rotator cuff disease (10 patients),
cubital tunnel syndrome (7 patients), thoracic outlet
syndrome (4 patients), or other problems (13 patients).
The mean age was 54.1 years (SD 14.9 years, range 20–
81 years). After informed consent was obtained from
the patients to participate in this study, they answered
the questionnaire. The DASH-JSSH questionnaire, the
official Japanese version of the 36-item short-form
health survey (SF-36, version 1.2)21,22 and the Visual
Analog Scale (VAS) (0–10 scale) for pain. The data
collected from the 72 patients were used as a baseline
value. Among the 72 patients, the 38 who had no
therapy during the consecutive outpatient visits were
readministered the DASH-JSSH questionnaire and
VAS for pain 1 or 2 weeks later. The 17 patients with
carpal tunnel syndrome who underwent carpal tunnel
release by three hand surgeons answered the DASH-
JSSH questionnaire and the VAS for pain twice
preoperatively and postoperatively (3 months after sur-
gery). The protocol of this study was reviewed and ap-
proved by the institutional review board prior to this
implementation.
Assessment of reliability, validity, and responsiveness
Reliability was investigated by looking at the reproduc-
ibility and internal consistency based on the test-retest
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method. The following analysis was conducted to exam-
ine the validity. A principal component analysis was
conducted to examine the construct validity and the
unidimensionality of the DASH-JSSH disability/
symptom (DASH-JSSH-DS) and DASH-JSSH work
(DASH-JSSH-W) scales. Completeness of item re-
sponses of the DASH-JSSH and VAS for pain was
examined. Correlation coefficients between the
DASH-JSSH and the SF-36 were obtained, and the fol-
lowing hypotheses were examined to investigate con-
current validity: (1) “Physical functioning” (SF-36-PF)
or “role-physical” (SF-36-RP) would exhibit the strong-
est association. (2) “Bodily pain” (SF-36-BP) would
exhibit the next strongest association. (3) “Mental
health” (SF-36-MH) and “vitality” (SF-36-VT) would
exhibit the weakest association.
Correlation coefficients between the DASH-JSSH-
DS and the DASH-JSSH-W or the DASH-JSSH sport/
music (DASH-JSSH-SM) scales were also obtained.
Correlation coefficients between the DASH-JSSH-
DS and the SF-36 were obtained. Correlation coeffi-
cients between the DASH-JSSH and VAS for pain were
obtained, and the criterion-based validity investigation
looked at the following hypothesis: The correlation be-
tween the DASH-JSSH and VAS for pain would be
high. The responsiveness was examined by calculating
the standardized response mean (SRM) (mean change/
SD)23 and effect size (mean change/SD of baseline
value)24 after carpal tunnel release of the patients with
carpal tunnel syndrome.
Statistical analysis
Kolmogorov-Smirnov and Liliefors probability tests
were used to assess distribution of the DASH-JSSH,
SF-36, VAS for pain, ages of the subjects, time required
to fill out the questionnaires of the DASH-JSSH and
SF-36. The interval measurements [DASH-JSSH-DS,
DASH-JSSH-SM, SF-36-BP, general health subscale of
SF-36 (SF-36-GH), SF-36-VT, SF-36-MH, VAS, age,
time required], were normally distributed, and there-
fore correlation was assessed using a parametric test
(Pearson’s correlation). The other interval measure-
ments [DASH-JSSH-W, SF-36-PF, SF-36-RP, social
functioning subscale of SF-36 (SF-36-SF) and role-
emotional subscale of SF-36 (SF-36-RE)] were not
normally distributed, and therefore correlation was as-
sessed using a nonparametric test (Spearman’s correla-
tion). Crohnbach’s alpha was used to assess internal
consistency. Instrument test-retest reliability was as-
sessed with the intraclass correlation coefficient (ICC).
All statistical analyses were conducted using the Sta-
tistical Package for Social Science (SPSS) version 12.0J
software. The critical values for significance were set at
P < 0.05.
Results
Completeness of item responses
No patients had difficulty completing the DASH-JSSH
questionnaire. It took them 8min 1 s, on average, to
finish the questionnaire: 95% confidence interval (95%
CI): 7min 2s to 9 min 1s. Most of the patients consid-
ered all the items of the DASH-JSSH-DS section to be
clear. Of the 72 patients, 9 (nonrespondent group) did
not answer one or more items of DASH-JSSH-DS.
None of them failed to answer more than three items.
Seven patients did not answer item 21 regarding sexual
activity. Three patients did not respond to item 19. Five
patients did not respond to items 2, 7, 8, 18, and 25, with
each item unanswered by one of them. The mean age
(64 ± 12 years) of the nonrespondent group (n = 9)
was significantly higher than the mean age (53 ± 15
years) of the respondent group (n = 63) who completed
all the items (P = 0.038). Of the 72 patients, 55 (76%)
answered the DASH-JSSH-W. However, only 15 of
the 72 (21%) patients responded to the DASH-JSSH-
SM.
The mean DASH-JSSH scores, mean SF-36 subscale
scores, mean VAS, and their ranges are shown in Table
1. The numbers of ceiling and floor scores of the DASH-
JSSH questionnaire, SF-36 subscales and VAS are
shown in Table 2. No patients recorded the minimum
disability score of 0 on the DASH-JSSH-DS (ceiling) or
the maximum disability score of 100 on the DASH-
Table 1. Scores for DASH-JSSH, SF-36, and VAS
Score
Instrument No. Mean (SD) Median Range
DASH-JSSH-DS 72 28 (21) 25 3–93
DASH-JSSH-W 55 33 (32) 25 0–100
DASH-JSSH-SM 15 47 (43) 44 0–100
SF-36-PF 72 72 (24) 80 0–100
SF-36-RP 72 48 (41) 50 0–100
SF-36-BP 72 47 (23) 42 0–100
SF-36-GH 72 50 (21) 49 5–97
SF-36-VT 72 56 (25) 57 0–100
SF-36-SF 72 76 (26) 88 13–100
SF-36-RE 72 55 (43) 67 0–100
SF-36-MH 72 61 (25) 60 8–100
VAS [0–10] 72 4.7 (2.8) 5.0 0–10
DASH-JSSH-DS, disability/symptom scale of DASH-JSSH; DASH-
JSSH-W, work module of DASH-JSSH; DASH-JSSH-SM, sport/mu-
sic module of DASH-JSSH; SF-36-PF, physical functioning subscale
of the 36-item Short-Form Health Survey (SF-36); SF-36-RP, role-
physical subscale of SF-36; SF-36-BP, bodily pain subscale of SF-36;
SF-36-GH, general health subscale of SF-36; SF-36-VT, vitality
subscale of SF-36; SF-36-SF, social functioning subscale of SF-36; SF-
36-RE, role-emotional subscale of SF-36; SF-36-MH, mental health
subscale of SF-36; VAS [0–10], Visual Analog Scale for pain [0–10
scale]
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JSSH-DS (floor). Twelve and four patients had the
maximum scores, and three and four patients had
the minimum scores, for the DASH-JSSH-W and the
DASH-JSSH-SM, respectively.
Reliability
Internal consistency was assessed by use of Cronbach’s
alpha coefficient. The alpha coefficient for the 30 items
in the DASH-JSSH-DS was high (0.962). When the
alpha coefficient was calculated for each of the 30 items
by eliminating each item, one by one, the range was
0.959–0.963; and no items were found to change the
internal consistency substantially. The alpha coeffi-
cients for the four items in the DASH-JSSH-W and
DASH-MS were also high (0.967 and 0.985, respec-
tively). When the alpha coefficients were calculated for
each of the four items by eliminating each item, one by
one, the ranges were 0.952–0.963 and 0.971–0.989, re-
spectively. No items were found to change the internal
consistency substantially.
Instrument test-retest reliability was assessed with
the intraclass correlation coefficient (ICC). There were
38 patients for the test-retest reliability, and the period
between the first and second tests was a mean of 9.2
days (range 6–17 days). The ICC for the DASH-JSSH-
DS was 0.82 (95% CI 0.69–0.90). The ICCs for the
DASH-JSSH-W and DSSH-JSSH-SM were 0.85 (95%
CI 0.70–0.93) and 0.91 (95% CI 0.64–0.98), respectively.
All ICCs for the DASH-JSSH indicate sufficient
reproducibility.
Validity
A principal component analysis was conducted to con-
firm the unidimensionality of the DASH-JSSH-DS. The
first factor had an eigenvalue (amount of variation in
the total sample accounted for by that factor)16 of 14.65,
which explained the 49% total variance of the DASH-
JSSH-DS scores of the patients. The unidimensionality
was found to be strong as a result of a substantial differ-
ence between the first and the second factors
(eigenvalue 2.80) (Fig. 1). When looking at the first
factor loading for each item, all items except item 24
exhibited loading (the correlation with the total score)
of 0.4 or higher (Table 3) and communalities of more
than 0.6, except question 30 (communality 0.47). The
unidimensionality of the DASH-JSSH-W was also
confirmed by a principal component analysis. The
eigenvalue for the first factor was 3.652, which ex-
plained the 91% total variance of the DASH-JSSH-W
scores of the patients. Furthermore, the unidimen-
sionality of the combined items for the DASH-
JSSH-DS and the DASH-JSSH-W was also confirmed
by a principal component analysis (Fig. 2). The
eigenvalue for the first factor was 17.94, which ex-
plained the 53% total variance of the combined scores
of the patients. The unidimensionality was found to be
strong as a result of a substantial difference between the
first and second factors (eigenvalue 2.68). All combined
items exhibited first loading (the correlation with the
total score) of more than 0.4 and communalities of more
than 0.7.
The correlations between the DASH-JSSH-DS score
and the subscales of the SF-36 scale ranged from -0.29
to -0.73 (Table 4). The strongest correlation was ob-
served in “role-physical” followed by “physical func-
tioning” and “bodily pain.” The correlation between
DASH-JSSH-DS and “mental health” or “vitality” was
somewhat weak. These results support the hypothesis
set down in advance except the strongest correlation
(Table 4). Correlation coefficients between the DASH-
Table 2. Ceiling and floor scores for DASH-JSSH, SF-36, and
VAS
No. No.
Instrument scale No. ceiling scoresa floor scoresb
DASH-JSSH-DS 72 0 0
DASH-JSSH-W 55 12 (22%) 3 (6%)
DASH-JSSH-SM 15 4 (27%) 4 (27%)
SF-36-PF 72 4 (6%) 1 (1%)
SF-36-RP 72 18 (25%) 24 (34%)
SF-36-BP 72 3 (4%) 2 (3%)
SF-36-GH 72 0 0
SF-36-VT 72 1 (1%) 2 (3%)
SF-36-SF 72 31 (43%) 0
SF-36-RE 72 29 (41%) 23 (32%)
SF-36-MH 72 2 (3%) 0
VAS [0–10] 72 4 (6%) 2 (3%)
a Maximum health status scores
b Minimum health status scores
Fig. 1. Scree plot of the principal components in the disability/
symptom scale of Disability of the Arm, Shoulder, and
Hand — Japanese Society for Surgery of the Hand (DASH-
JSSH-DS)
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JSSH-DS and the DASH-JSSH-W or the DASH-JSSH-
SM were 0.79 and 0.82, respectively (Table 4) (P < 0.01).
These results indicate strong correlations between the
DASH-JSSH-DS and the DASH-JSSH-W and between
the DASH-JSSH-DS and the DASH-JSSH-SM.
The correlations between the DASH-JSSH-W score
and the subscales of the SF-36 scale ranged from -0.38
to -0.77 (Table 4). These correlations were similar to
the correlations between the DASH-JSSH-DS score
and the subscales of the SF-36 scale. The correlations
between the DASH-JSSH-SM score and the subscales
of the SF-36 scale were weak and ranged from 0.12
to -0.65 (Table 4).
No statistical difference in age was found between
men and women (P = 0.161). The DASH-JSSH-DS
mean score was 49.9 (SD 4.7) for men and 55.4 (SD 1.8)
for women. There was no statistical difference between
them (P = 0.194). This result supports our hypothesis.
The correlation between the DASH-JSSH-DS score
and age was weak (r = 0.296, P < 0.05).
The correlation between the DASH-JSSH-DS score
and the degree of pain was examined and observed as
moderate for the SF-36 bodily pain score and the VAS
for pain (Table 4). The correlation between the DASH-
JSSH-W score and the degree of pain was also exam-
ined and observed as moderate for the SF-36 bodily
pain score and the VAS for pain (Table 4).
Responsiveness
Of 38 patients with carpal tunnel syndrome, 17 under-
went carpal tunnel release. They completed the DASH-
JSSH and VAS for pain 3 months after the surgery. The
mean subject age was 57 years (SD 10 years; range 48–
78 years). There were 16 females and one male. Of the
17 patients, 13 completed the DASH-JSSH-W, and
those scores were included for this study. On the other
hand, only 3 of the 17 patients completed the DASH-
JSSH-SM, so this score was excluded for this study. All
scores for DASH-JSSH-DS, DASH-JSSH-W, and VAS
for pain were normally distributed. The calculated SRM
and effect size of DASH-JSSH-DS, DASH-JSSH-W,
and VAS for pain were -0.48/-0.26, -0.68/-0.41, and
-0.40/-0.40, respectively. There was no statistical
difference between the mean values of preoperative
and postoperative DASH-JSSH-DS scores (P = 0.068).
There was a statistical difference between the mean
values of preoperative and postoperative DASH-JSSH-
W scores (P = 0.030). There was no statistical difference
between the mean value of preoperative and postopera-
tive VAS scores for pain (P = 0.119). DASH-JSSH-DS
and DASH-JSSH-W were as moderately sensitive as
VAS for pain.
Discussion
Japanese adaptation of the DASH questionnaire was
performed following a systematic standardized ap-
proach.19,20 The purpose of this study was to examine the
Table 3. Factor loading (unrotated) of principal components
of DASH-JSSH-DS
Item no. Loading
1 0.631
2 0.707
3 0.752
4 0.770
5 0.817
6 0.763
7 0.814
8 0.843
9 0.820
10 0.683
11 0.797
12 0.831
13 0.767
14 0.731
15 0.632
16 0.702
17 0.745
18 0.722
19 0.759
20 0.585
21 0.708
22 0.621
23 0.787
24 0.323
25 0.404
26 0.612
27 0.667
28 0.497
29 0.545
30 0.606
Fig. 2. Scree plot of the principal components in combined
items of DASH-JSSH-DS and the work module of DASH-
JSSH (DASH-JSSH-W)
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psychometric qualities of the DASH-JSSH by assessing
its psychometric standards in the area of the reliability,
validity, and responsiveness.
The DASH-JSSH consists of a 30-item scale and two
optional 4-item scale modules. It took patients a similar
amount of time to complete the DASH-JSSH compared
with the time to complete the other language versions.13
This indicated that the questionnaire was easy to under-
stand. Elderly patients left no more than three items
unanswered, and those were thought to be pertaining to
specific activities, such as sexual and recreational activi-
ties, not performed by those individuals.
The lack of floor and ceiling effects assure the authors
of the validity of this version of the DASH-JSSH-DS.
The validation process of the DASH-JSSH scale has
shown that it has reliability similar to that of the other
language versions12–18 including the original one.25 This
scale, as was the original DASH scale, was developed
for clinical assessment of a patient group, not of indi-
vidual patients.22 Internal consistency needs to be
higher than 0.95 if a scale is to be used for tracking
individual patients.26 Most translated versions of the
DASH12,14–17 and the original one6 had internal consist-
ency higher than 0.95. Thus, most language versions of
the DASH, including the Japanese version, could be
used with caution for daily assessment of individual
patient status over time.
The validation process of the DASH-JSSH question-
naire has shown that it has validity similar to that of the
other language versions,12,14–18 including the original
DASH.25 The strong correlations between the DASH-
JSSH-DS and SF-36 subscales (role of physical health,
physical functioning, and bodily pain) support this va-
lidity and demonstrate results similar to those of the
validation papers for the other language versions in-
cluding the original DASH.
The strong correlations between the DASH-JSSH-W
and SF-36 subscales (role of physical health, physical
functioning, and bodily pain) support this validity and
demonstrate results similar to those of the validation
paper for the Italian version.17 The correlations between
the DASH-JSSH-SM and SF-36 subscales were weak
and demonstrated results similar to those of the valida-
tion paper for the Italian version17 because of the small
sample size. This area needs further investigation.
These results demonstrated that the DASH-JSSH
(especially DASH-JSSH-DS and DASH-JSSH-W)
measures the important elements that make up health-
related QOL.
The DASH-JSSH-DS scale exhibited high uni-
dimensionality, and there was no low item-scale cor-
relation. These results were similar to those of the
Dutch version.16 The DASH-JSSH-W scale also exhib-
ited high unidimensionality, and there was no low item-
scale correlation. The communalities of these two scales
(DASH-JSSH-DS and DASH-JSSH-W) were high.
These results show that the DASH-JSSH-W has a high
quality of validation.
Cohen’s rule-of-thumb for interpreting the “effect
size index” — a value of 0.2 is small, 0.5 is moderate,
and 0.8 or greater is large — can be applied to the
SRM.23 The responsiveness of the DASH-JSSH-DS and
DASH-JSSH-W for the patients with carpal tunnel syn-
drome was moderate 3 months after carpal tunnel re-
lease operation, although other studies showed a higher
responsiveness of the DASH-DS than our results.27
There was no statistical difference between the mean
value of preoperative and postoperative DASH-JSSH-
DS scores. This is thought to be due to the small sample
size and requires further investigation.
We believe the strengths of this study are that the
DASH-JSSH-W and DASH-JSSH-DS scales demon-
strated good reproducibility, consistency, and validity.
Moreover, both of them had moderate responsiveness.
A limitation of this present study is that we cannot
successfully validate the DASH-JSSH-SM because the
Table 4. DASH-JSSH, SF-36, VAS, and their correlations
Correlation coefficients with
Instrument scale No. DASH-JSSH-DS‡ DASH-JSSH-W# DASH-JSSH-SM‡
DASH-JSSH-DS‡ 72 — — —
DASH-JSSH-W# 55 0.79** — —
DASH-JSSH-SM‡ 15 0.82** 0.58* —
SF-36-PF# 72 -0.62** -0.45** -0.65**
SF-36-RP# 72 -0.73** -0.77** -0.72**
SF-36-BP‡ 72 -0.61** -0.47** -0.24
SF-36-GH‡ 72 -0.44** -0.52** 0.19
SF-36-VT‡ 72 -0.36** -0.42** -0.15
SF-36-SF# 72 -0.29** -0.38* 0.12
SF-36-RE# 72 -0.53** -0.55** -0.04
SF-36-MH‡ 72 -0.38** -0.42** -0.17
VAS [0–10]‡ 72 0.47** 0.64** 0.45
*P < 0.05; ** P < 0.01; ‡ Pearson’s correlation; # Spearman’s correlation
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sample size was relatively small and the patient’s re-
sponse rate was low. The samples of this study are not
representative of the general population.
Conclusions
We have concluded that the DASH-DS and DASH-W
Japanese version have evaluation capacities equivalent
to those of the other language versions of the DASH.
We expect that use of these scales in Japan to assess
treatment by the patients themselves will contribute to
meaningful improvement of outcome for patients with
upper extremity disorders.
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